Literature DB >> 31008265

Ischemic stroke in the young: Current perspectives on incidence, risk factors, and cardiovascular prognosis.

Jukka Putaala1.   

Abstract

About one-fourth of ischemic strokes occur in working-aged individuals in the high-income countries, with worldwide increasing incidence in this age group from 1980s to present. Recent evidence suggests that traditional vascular risk factors are more prevalent than previously suggested in young adult stroke patients and they accumulate with age particularly in men. Accordingly, relatively high rates of atherosclerotic changes have been detected in these patients. The strength of association of vascular risk factors has gone poorly studied, however. Many young patients with ischemic stroke have, in turn, no traditional risk factors, while they may harbor other conditions with weak or uncertain association with the stroke alone. These individual conditions often represent a risk factor that may be strictly young-age specific, more prevalent in younger than older stroke patients (e.g. patent foramen ovale), or more prevalent among the young in the population. Despite high rates of vascular risk factors and atherosclerotic changes, these findings do not translate to higher frequencies of identified classical stroke mechanisms. In fact, cryptogenic causes are markedly common and even more frequent among the very young patients. Limited randomized trial evidence exists to support secondary prevention decision-making in patients, yet they face an increased risk of death and future vascular events for years to come-dependent on risk factor profile and cause of the stroke. This review provides an overview of recent data on epidemiology, risk factors, and their strength of association in ischemic stroke in the young. Furthermore, the relationship between with the risk factors and cardiovascular outcomes and key features on the evidence related to secondary prevention will be discussed.

Entities:  

Keywords:  Stroke in young adults; incidence; patent foramen ovale; pathogenesis; prognosis; risk factors

Year:  2016        PMID: 31008265      PMCID: PMC6301217          DOI: 10.1177/2396987316629860

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN: 2396-9873


  14 in total

Review 1.  Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Authors:  Bharath Chelluboina; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

Review 2.  Risk Factors for Ischemic Stroke in Younger Adults: A Focused Update.

Authors:  Mary G George
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

3.  Multi-level outcomes for young adults with acquired brain injury through a remote intensive cognitive rehabilitation approach: a pilot intervention study.

Authors:  Christianna Gilbert; Grace Mooradian; Anne Citorik; Natalie Gilmore; Swathi Kiran
Journal:  Brain Inj       Date:  2022-02-19       Impact factor: 2.167

4.  Global Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis.

Authors:  Mina A Jacob; Myrna ME van Dongen; Merel S Ekker; Karoliina Aarnio; Arunkar K Annamalai; Antonio Arauz; Marcel Arnold; Miguel A Barboza; Manuel Bolognese; Raf Brouns; Batnairamdal Chuluun; Enkhzaya Chuluunbaatar; Byambasuren Dagvajantsan; Stephanie Debette; Adi Don; Chris Enzinger; Esme Ekizoglu; Simon Fandler-Höfler; Franz Fazekas; Anette Fromm; Thomas Gattringer; Giosue Gulli; Michael Hoffmann; Thiago F Hora; Christina Jern; Katarina Jood; Masahiro Kamouchi; Young Seo Kim; Takanari Kitazono; Steven J Kittner; Timothy J Kleinig; Catharina J M Klijn; Janika Korv; Tsong-Hai Lee; Didier Leys; Noortje AM Maaijwee; Nicolas Martinez-Majander; João Pedro Marto; Man M Mehndiratta; Victoria Mifsud; Vinicius V Montanaro; Mayowa O Owolabi; Vinod B Patel; Matthew C Phillips; Bartlomiej Piechowski-Iozwiak; Aleksandra Pikula; Jose Luis Ruiz-Sandoval; Bettina Sarnowski; Floris HBM Schreuder; Rick H Swartz; K S Tan; David Tanne; T Tatlisumak; Vincent Thijs; Anil M Tuladhar; Miguel Viana-Baptista; Riina Vibo; Teddy Y Wu; Nilüfer Yesilot; Ulrike Waje-Andreassen; Alessandro Pezzini; Jukka Putaala; Frank-Erik de Leeuw
Journal:  BMJ Open       Date:  2019-11-14       Impact factor: 2.692

5.  Too Young to Have a Stroke?-a Global Health Crisis.

Authors:  Amey Vrudhula; Jing Zhao; Renyu Liu
Journal:  Stroke Vasc Neurol       Date:  2019-12-24

6.  Why Me?: A Qualitative Study on the Experiences of Young Stroke Survivors in the Accra Metropolis of Ghana, West Africa.

Authors:  Sussana Opoku; Cecilia Eliason; Albert Akpalu
Journal:  J Patient Exp       Date:  2020-10-27

7.  Epidemiology of Young Stroke in the Ludhiana Population-Based Stroke Registry.

Authors:  Monika Singla; Gagandeep Singh; Paramdeep Kaur; Jeyaraj D Pandian
Journal:  Ann Indian Acad Neurol       Date:  2022-02-08       Impact factor: 1.383

8.  Young ischaemic stroke incidence and demographic characteristics - The Norwegian stroke in the young study - A three-generation research program.

Authors:  Beenish Nawaz; Geir E Eide; Annette Fromm; Halvor Øygarden; Kristin M Sand; Lars Thomassen; Halvor Næss; Ulrike Waje-Andreassen
Journal:  Eur Stroke J       Date:  2019-07-16

9.  Prevalence and short-term changes of cognitive dysfunction in young ischaemic stroke patients.

Authors:  D Pinter; C Enzinger; T Gattringer; S Eppinger; K Niederkorn; S Horner; S Fandler; M Kneihsl; K Krenn; G Bachmaier; F Fazekas
Journal:  Eur J Neurol       Date:  2019-01-09       Impact factor: 6.089

10.  Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke.

Authors:  Irma Isordia-Salas; Manuel Martínez-Marino; Paolo Alberti-Minutti; María Tania Ricardo-Moreno; Ricardo Castro-Calvo; David Santiago-Germán; José Antonio Alvarado-Moreno; Cristian Calleja-Carreño; Jesús Hernández-Juárez; Alfredo Leaños-Miranda; Abraham Majluf-Cruz
Journal:  Dis Markers       Date:  2019-10-30       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.